Hyderabad: BioAsia, the pioneering annual event dedicated to the lifesciences sector, is poised to revolutionize the landscape with its 21st edition, BioAsia 2024, scheduled from February 26 to 28, 2024. With the overarching theme of "Data and AI: Redefining Possibilities," this event is not just taking shape; it's transforming the future of lifesciences.
The keynote speakers include Dave Ricks, CEO of Eli Lilly, Dr. Chris Boerner, Incoming CEO of BMS, Geoff Martha, Chairman and CEO, Medtronic, Christophe Weber, CEO of Takeda and Nobel Laureate Prof. Gregg Semenza.
These keynote speakers span the breadth of lifesciences expertise, making BioAsia 2024 an unparalleled forum and networking opportunity.
Minister for Industries and Commerce, IT, Electronics & Communications KT Rama Rao expressed the importance of BioAsia: "BioAsia's global prominence reflects Telangana's unwavering commitment to innovation and research. We are privileged to host these visionary leaders who are shaping the future of healthcare."
Shakthi M. Nagappan, CEO of Telangana Lifesciences & BioAsia emphasized the event's global stature: "BioAsia 2024 is a game-changer, attracting the world's brightest lifesciences minds. The participation of global CEOs and visionaries underscores BioAsia's growing global influence, and we are very hopeful that some more influential leaders will join this already impressive lineup""
Principal Secretary I&C Mr. Jayesh Ranjan remarked, "BioAsia has evolved into an international congregation that brings together the finest minds in the lifesciences domain. With influential keynotes, insightful panel discussions, and collaborative networking opportunities, BioAsia continues to be a frontrunner in shaping the lifesciences landscape. "
The event is being organized in partnership with EY India as Knowledge Partner.
Commenting on the development Suresh Subramanian, Partner/Principal & National Life Sciences Leader, Business Consulting, EY, said “BioAsia has been recognised as a catalyst fostering transformative ideas and partnerships and is an eagerly awaited Global Event. EY is privileged to be playing a key role as knowledge partners with the Govt. of Telangana over the years in making BioAsia a Global Brand. Truly this event continues to spearhead India’s arrival and growing importance in the Global Life Sciences and Healthcare map and does much to foster collaborations with Global giants. Kudos to the Telangana Govt for its untiring and sustained efforts in bettering BioAsia every year.”
BioAsia has earned global recognition as a premier lifesciences event, and the presence of these eminent leaders underscores Telangana's position as a lifesciences powerhouse. BioAsia 2024 is destined to be a milestone event, propelling the frontiers of lifesciences and healthcare into uncharted territories. BioAsia 2024 promises to redefine the future of healthcare and research at the intersection of data, AI, and lifesciences.
